Blog - Page 4069 of 5386

MondayNov 03, 2008 4:56 am

CAS Medical Systems, Inc. (NASDAQ: CASM)

CAS Medical Systems, Inc. (NASDAQ: CASM) is focused on designing and manufacturing novel, non-invasive technologies and products essential to patient care in the most challenging clinical environments. The company’s products are used by clinicians worldwide and are recognized for their highest quality. Each and every individual at CAS Medical is dedicated to demonstrating the highest standards of innovation, quality, service and performance. For further information, visit the Company's web site at www.casmed.com.

MondayNov 03, 2008 4:55 am

Platinum Australia Limited (ASX: PLA AU)

Platinum Australia Limited (ASX: PLA AU) is committed to discovering and developing Platinum Group Metal ("PGM") Projects in Australia and around the world. In South Africa, the company is developing the Smokey Hills PGM Project which is scheduled to commence production in the first half of 2008. This project consists of an open pit and underground mining operation with an onsite processing facility capable of producing ~100,000 oz 4E PGM per annum. For further information, visit the Company's web site at www.platinumaus.com.au.

MondayNov 03, 2008 4:55 am

Adeona Pharmaceuticals, Inc. AEN)

Adeona Pharmaceuticals, Inc. (AEN), a development-stage, specialty pharmaceutical company, has dedicated its efforts to developing proprietary, late-stage drug candidates designed to treat autoimmune and central nervous system (CNS) diseases. The company’s strategy is to exclusively in-license proprietary, clinical-stage drug candidates that have proven clinical efficacy for the treatment medical diseases that are as of yet unattended to. For further information, visit the Company's web site at www.adeonapharma.com.

MondayNov 03, 2008 4:54 am

Carrizo Oil & Gas, Inc. (NASDAQ: CRZO)

Carrizo Oil & Gas, Inc. (NASDAQ: CRZO), a Houston based independent energy company, focuses on the exploration, development and production of natural gas and oil. The company’s current operations are concentrated in the Barnett Shale area of North Texas and the U.K. North Sea where two significant discoveries were made last year. Through the leveraging of a 3-D seismic database, Carrizo’s staff is continually adding to and refining the company’s substantial inventory of drilling locations. For further information, visit the Company's web site at www.carrizo.cc.

MondayNov 03, 2008 4:54 am

PhotoMedex, Inc. (NASDAQ: PHMD)

PhotoMedex, Inc. (NASDAQ: PHMD) provides novel solutions designed for application in the areas of dermatology, therapeutic skin care and surgical products & services. The company is currently developing proprietary excimer laser and fiber-optic systems to treat dermatological applications such as psoriasis and vitiligo. PhotoMedex’s XTRAC® was the first FDA market-cleared excimer laser system designed to treat dermatological applications such as psoriasis and vitiligo. For further information, visit the Company's web site at www.photomedex.com.

MondayNov 03, 2008 4:54 am

PharmAthene, Inc. (AMEX: PIP)

PharmAthene, Inc. (AMEX: PIP) is focused on addressing the critical needs of the United States and its allies through the development and commercialization of medical countermeasures against biological and chemical weapons. Currently, the company’s lead product development programs include: SparVax, an anthrax vaccine; a third generation rPA anthrax vaccine; Valortim, an antibody designed to prevent and treat anthrax infection; Protexia, a bioscavenger; and RypVax, a dual antigen vaccine for plague. For further information, visit the Company's web site at www.pharmathene.com.

MondayNov 03, 2008 4:54 am

Capstone Therapeutics (NASDAQ: CAPS)

Capstone Therapeutics (NASDAQ: CAPS), a biotechnology company, is focused on developing a pipeline of innovative therapeutic peptides designed to help patients with under-served medical conditions. The Company is currently committed to developing and commercializing two product platforms: AZX100 and Chrysalin® (rusalatide acetate or TP508). AZX100 is currently under evaluation for commercially significant medical applications such as treating pulmonary disease, and Chrysalin is currently under evaluation for treating disorders that involve vascular endothelial dysfunction. For further information, visit the Company's web site at www.capstonethx.com.

MondayNov 03, 2008 4:53 am

Pharmasset, Inc. (NASDAQ: VRUS)

Pharmasset, Inc. (NASDAQ: VRUS), a clinical-stage pharmaceutical company, is focused on discovering, developing and commercializing innovative drugs for the treatment of viral infections. The company’s primary focus is on developing of oral therapeutics for the treatment of hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). Their product candidates include: Clevudine (for treating chronic HBV infection), R7128 (for treating HCV), and R7128 (for treating HIV). For further information, visit the Company's web site at www.pharmsset.com.

MondayNov 03, 2008 4:53 am

Capitol Acquisition Corporation (AMEX: CLA)

Capitol Acquisition Corporation (AMEX: CLA) is a blank check company formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination, one or more operating businesses or assets. Located in Washington, DC, Capitol is led by their CEO Mark D. Ein. For further information, visit the company website at: www.venturehousegroup.com.

MondayNov 03, 2008 4:53 am

Pharmacopeia, Inc. (NASDAQ: PCOP)

Pharmacopeia, Inc. (NASDAQ: PCOP), a clinical development stage biopharmaceutical company, is focused on discovering and developing innovative small molecule therapeutics to attend to significant medical needs. The company’s broad portfolio of clinical and preclinical candidates are currently under development internally or with partners, including nine clinical compounds in Phase 2 or Phase 1 development. For further information, visit the Company's web site at www.pcop.com.

Site Search

Company Search

CAS Medical Systems, Inc. (NASDAQ: CASM)

Platinum Australia Limited (ASX: PLA AU)

Adeona Pharmaceuticals, Inc. AEN)

Carrizo Oil & Gas, Inc. (NASDAQ: CRZO)

PhotoMedex, Inc. (NASDAQ: PHMD)

PharmAthene, Inc. (AMEX: PIP)

Capstone Therapeutics (NASDAQ: CAPS)

Pharmasset, Inc. (NASDAQ: VRUS)

Capitol Acquisition Corporation (AMEX: CLA)

Pharmacopeia, Inc. (NASDAQ: PCOP)

Market Basics

Newsletter Publishers

Public Companies